Romidepsin is a histone deacetylase inhibitor and epigenetic modulator used to treat cutaneous T-cell lymphoma by inducing apoptosis in malignant cells through altered gene expression. This category includes… Read more
![Chemical structure of (1S,1'S,4R,4'R,8R,8'R,11S,11'S)-8,8'-((1E,1'E)-Disulfanediylbis(but-1-ene-4,1-diyl))bis(4,11-diisopropyl-15-methyl-9-oxa-16-thia-2,5,12,19-tetraazabicyclo[12.3.2]nonadecane-3,6,10,13,18-pentaone)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S1S4R4R8R8R11S11S-88-1E1E-Disulfanediylbisbut-1-ene-41-diylbis411-diisopropyl-15-methyl-9-oxa-16-thia-251219-tetraazabicyclo12.3.2nonadecane-36101318.png&w=3840&q=75)



Romidepsin is a histone deacetylase inhibitor and epigenetic modulator used to treat cutaneous T-cell lymphoma by inducing apoptosis in malignant cells through altered gene expression. This category includes reference standards for the active pharmaceutical ingredient, as well as a comprehensive range of related impurities, degradation products, and metabolites. Pharmaceutical laboratories utilize these materials for critical analytical tasks, including impurity profiling and the validation of analytical methods. Furthermore, the inclusion of stable isotope labelled compounds provides the essential internal standards required for accurate quantification in complex biological matrices or during stability testing. By accessing these materials, laboratories can maintain rigorous quality control protocols throughout the drug development and manufacturing lifecycle of this specific antineoplastic agent.